Towards a more effective vaccine against tuberculosis

Of French and Italian researchers have developed an effective protection against the bacterium that causes tuberculosis in mice. Although results are preliminary, they raise the hope of tomorrow to have a more effective vaccine against the disease responsible for death of 1.5 million per year.

80% of TB patients live in sub-Saharan Africa. The limitations of BCG against pulmonary tuberculosis

drugs

Tuberculosis is one of the most prevalent diseases in the world. It is due to infection by the mycobacterium Mycobacterium tuberculosis , affecting one third of world population. Each year, nearly 9 million people developed tuberculosis and nearly 1.5 million people die. About 80% of patients live in sub-Saharan Africa; it has not disappeared in France. Continue reading “Towards a more effective vaccine against tuberculosis”